Results 81 to 90 of about 59,961 (237)

Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: A prospective study [PDF]

open access: yes, 2008
Background Cell death mode has been studied in cancer, autoimmune, and neurodegenerative diseases. In this study, apoptosis and necrosis are investigated for the first time in patients with chronic calculous cholecystitis.
Constantinos Simopoulos   +31 more
core   +1 more source

Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the bioequivalence of orally administered orforglipron tablets and capsules in participants with obesity or overweight who were otherwise healthy. Materials and Methods This phase 1, multicenter, open‐label, multiple‐dose, dose‐escalation study was conducted in 429 healthy adults.
Xiaosu Ma   +5 more
wiley   +1 more source

Comparative Evaluation of Laparoscopic Cholecystectomy in Acute and Chronic Cholecystectomy

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2013
BACKGROUND AND OBJECTIVE: Laparoscopic cholecystectomy has been performed for the management of hepatobiliary diseases. Early laparoscopic cholecystectomy (LC) was contraindication for acute cholecystitis (AC).
AA Darzi,   +6 more
doaj  

Acute cholecystitis and helminthic infestation

open access: yesJournal of Acute Disease, 2019
Acute cholecystitis is an important acute medical problem, so acute disorder of the gall bladder requires good clinical management. There are several etiologies of acute cholecystitis.
Pathum Sookaromdee, Viroj Wiwanitkit
doaj   +1 more source

Quantitative Analysis of Troponin I Serum Values in Patients with Acute Cholecystitis [PDF]

open access: yes, 2012
The diagnosis and staging of acute cholecystitis, upon a lot of diagnostic methods and some scoring systems, is still a great clinical problem. The aim of the study was to investigate if serum Troponin I is elevated in patients with acute cholecystitis ...
Ivo Sjekavica   +10 more
core   +1 more source

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara   +3 more
wiley   +1 more source

Chronic Cholecystitis with Synchronized Candida Infection – A Rare Case from Rural India

open access: yesActa Medica Bulgarica
Background. Candida infection may cause acute, necrotizing or suppurative cholecystitis. Acute cholecystitis with Candida infection has been reported in patients with malignancies.
Dayal S.
doaj   +1 more source

Hemobilia due to cystic artery pseudoaneurysm: A rare late complication of laparoscopic cholecystectomy [PDF]

open access: yes, 2017
We discuss a patient with late presentation of hemobilia following cholecystectomy, which is unusual because pseudoaneurysm caused by vascular injury during surgery typically presents soon after surgery.
Badillo, Ricardo   +2 more
core   +2 more sources

Chronic ulcerative oesophagitis rich in IgG4‐positive plasma cells – a distinct clinicopathological entity

open access: yesHistopathology, EarlyView.
We report a series of 12 patients (mean age 63 years) with chronic oesophageal ulceration showing morphological features of IgG4‐related inflammatory disease. Most patients underwent several rounds of endoscopy until this association was recognized. The majority of patients went into clinical and histological remission following corticosteroid therapy.
Hanna Henzinger   +5 more
wiley   +1 more source

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. [PDF]

open access: yes, 2019
Pexidartinib (PLX3397) is a small molecule tyrosine kinase and colony-stimulating factor-1 inhibitor with FDA breakthrough therapy designation for tenosynovial giant-cell tumor, and currently under study in several other tumor types, including breast ...
Chien, A Jo   +5 more
core  

Home - About - Disclaimer - Privacy